Using a TMA of archival primary prostate cancer tissue linked to long-term clinical outcome data we have shown that EphA2 and pEphA2S897 are associated with substantially worse long-term survival in PTEN-deficient prostate cancer and that the migrational stimulatory effect is most pronounced at the tumour margin. Here, EPHA2 is linked to prostate carcinoma.